U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07071506) titled 'New Methods for Evaluating Preventive Migraine Treatment' on May 28.
Brief Summary: The study aims to estimate treatment effects in a balanced placebo design (BPD) to specify to which extent contextual factors interact in preventive migraine treatment and influence adverse event occurrence in patients with chronic migraine. Using a clinical within-subjects design, patients with chronic migraine will receive four treatment conditions in a randomized order.
Study Start Date: March 04
Study Type: INTERVENTIONAL
Condition:
Migraine
Migraine With or Without Aura
Headache Disorders
Chronic Migraine, Headache
Intervention:
DRUG: Acti...